Compare EHC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EHC | ICLR |
|---|---|---|
| Founded | 1983 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 13.1B |
| IPO Year | 1994 | 2001 |
| Metric | EHC | ICLR |
|---|---|---|
| Price | $123.72 | $171.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | $143.29 | ★ $178.62 |
| AVG Volume (30 Days) | 722.9K | ★ 883.9K |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 24.22 | N/A |
| EPS | ★ 3.47 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.33 | N/A |
| Revenue Next Year | $8.14 | N/A |
| P/E Ratio | $35.16 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $92.77 | $66.57 |
| 52 Week High | $127.99 | $203.91 |
| Indicator | EHC | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 55.08 |
| Support Level | $118.88 | $162.32 |
| Resistance Level | $127.50 | $181.71 |
| Average True Range (ATR) | 2.91 | 6.52 |
| MACD | -0.15 | 0.48 |
| Stochastic Oscillator | 77.81 | 75.02 |
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.